EMA committee backs Lilly's Foundayo pill for obesity and type 2 diabetes in the EU
The CHMP recommended approval of orforglipron, a once-daily GLP-1 pill with no food or water rules. The European Commission usually decides within weeks.
Recap by typeshit. Full story at Pharmaceutical Executive.